AUG 01, 2017 7:06 PM PDT

Uncovering HIV Hiding Spots in the Body

WRITTEN BY: Kara Marker

Scientists have known for a while that HIV hides in the body, undetected by the immune system and unaffected by antiretroviral drugs, but where specifically? Researchers from the University of Michigan have narrowed it down to specific cells in the bone marrow, highlighting a new opportunity for an anti-HIV drug that could finally get rid of the virus completely.


Credit: University of Michigan


HIV is hard to get rid of entirely. Despite the latest anti-retroviral drug technologies, HIV hides in the body, waiting to “pounce” once the drugs stop to cause an infection, which can lead to AIDS. The way HIV “lurks” is similar to the way the varicella virus, which causes chickenpox, hides out in long-living nerve cells and causes shingles later in life. Current drugs keep HIV at bay, preventing AIDS, but they don’t completely rid the body of the virus.

"Looking for the cells that harbor functional HIV is like searching for a needle in a haystack,” explained research leader Kathleen Collins, MD, PhD. “Our new results expand our understanding of the type of cells that can do it.”

Thanks to several long-term HIV patients who donated bone marrow samples, Collins and her team were able to observe HIV hiding in bone marrow cells, and they saw that HIV was present in many different cell types. Cells harboring the virus divide, passing HIV genetic material to future generations of cells.

They found that HIV hides in hematopoietic progenitor cells (HPCs), which replace blood cells as they get older and die, “blood cells in waiting.” Here, HIV hijacks the HPC’s cellular machinery so the cell starts cranking out viral proteins. To do so, HIV attaches to a CD4 receptor on the surface of HPCs. Two HIV subtypes are capable of binding CD4, those utilizing CXCR4 and CCR5 receptors.

HPCs can live for years, making them a smart choice for HIV to set up shop. However, identifying HPCs as HIV hideouts shows researchers exactly what cell type to target. Collins’s team is doing just that - researching new treatment options that can target HPCs specifically, leaving other bone marrow cells unharmed to minimize collateral damage.

"Today's medications have side effects, as well as financial costs,” Collins pointed out. “To get to the next step, we need to target the types of cells that form a latent infection, including these progenitor cells."

According to the Centers for Disease Control and Prevention, over one million people in the United States are living with HIV, and 1 in 7 of them are completely unaware.

The present study was published in the journal PLOS Pathogens.

Source: Michigan Medicine/University of Michigan, CDC

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog:
You May Also Like
FEB 23, 2020
FEB 23, 2020
New discovery could help preterm babies breathe easy
Babies born more than three weeks before full term are met with complicated and often life-threatening health challenges ...
MAR 19, 2020
MAR 19, 2020
All You Need to Know About Coronavirus (CoVID-19)
A new coronavirus, first identified in China in December 2019, has caused an outbreak of respiratory illness that was re ...
APR 16, 2020
Health & Medicine
APR 16, 2020
Structural Basis of Receptor Recognition by SARS-CoV-2
As mortality and infection rates rise globally, it appears that SARS-CoV-2, the virus responsible for the COVID-19 pande ...
APR 20, 2020
Drug Discovery & Development
APR 20, 2020
First Successful Vaccine for Middle-East Respiratory Syndrome
Researchers have successfully completed the first-in-human clinical trial for a vaccine against MERS (Middle East Respir ...
MAY 19, 2020
Drug Discovery & Development
MAY 19, 2020
COVID-19 Vaccine On Track for Late 2020
Moderna, a biotechnology company based in Massachusetts, has released information on its vaccine against COVID-19 from i ...
MAY 23, 2020
MAY 23, 2020
The FDA Yanks Some COVID-19 Antibody Tests From the Market
The massive demand for diagnostic testing led the FDA to open a short window for many testing products to go to market w ...
Loading Comments...